Bellevue Group Ag Essa Pharma Inc. Put Options Transaction History
Bellevue Group Ag
- $6.38 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding EPIX
# of Institutions
36Shares Held
35MCall Options Held
53.4KPut Options Held
29.4K-
Bvf Inc San Francisco, CA8.75MShares$43.9 Million2.22% of portfolio
-
Morgan Stanley New York, NY4.18MShares$21 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.59MShares$18 Million2.49% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.98MShares$15 Million1.25% of portfolio
-
Rtw Investments, LP New York, NY2.3MShares$11.5 Million0.31% of portfolio
About ESSA Pharma Inc.
- Ticker EPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,073,100
- Market Cap $221M
- Description
- ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...